Universe Pharmaceuticals Inc (UPC): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

$517.43M
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
2019-09-30: $418.4K2020-09-30: $410.1K2021-09-30: $446.9K2022-09-30: $533.9K2023-09-30: $508.79M2024-09-30: $485.73M2025-09-30: $517.43M$517.43M
2019-09-30 Depreciation & Amortization (USD) 2025-09-30
Period endedDepreciation & AmortizationChange YoYSource filing
2025-09-30$517.43Mn/a2026-01-29, From 2024-10-01
2024-09-30$485.73Mn/a2026-01-29, From 2023-10-01
2023-09-30$508.79Mn/a2026-01-29, From 2022-10-01
2022-09-30$533.9Kn/a2025-04-29, From 2021-10-01
2021-09-30$446.9Kn/a2024-01-30, From 2020-10-01
2020-09-30$410.1Kn/a2023-02-10, From 2019-10-01
2019-09-30$418.4Kn/a2022-01-31, From 2018-10-01